The health department of Canadian Government has allowed Aurobindo Pharma for submission of its abbreviated new drug, Gabapentin capsules in 100mg, 300mg and 400mg strengths.
Aurobindo Pharma is a Hyderabad-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients (APIs). The company is already supplying some generic drugs in the Canadian market. The recent approval by Canadian health body is the sixth approval received by Indian Pharmaceutical major.